The effect of gadoxetic acid enhancement on lesion detection and characterisation using T 2 weighted imaging and diffusion weighted imaging of the liver

British Journal of Radiology

Volumn 85, Issue 1009, 2012, Pages 29-36

  Choi, S A ^a,b   Lee, Seung Soo ^a   Jung, I H ^a   Kim, H A ^a   Byun, J H ^a   Lee, M G ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Eulji University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CYST; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; FOCAL HEPATIC LESION; HEMANGIOMA; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RATING SCALE; RECEIVER OPERATING CHARACTERISTIC; SINGLE BLIND PROCEDURE; T2 WEIGHTED IMAGING;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 84455196447     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/12929687     Document Type: Article

References (27)

1. Halavaara J, Breuer J, Ayuso C, Balzer T, Bellin MF, Blomqvist L, et al. Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT - a multicenter trial. J Comput Assist Tomogr 2006;30:345-54. (Pubitemid 43922248)
2. Hammerstingl R, Huppertz A, Breuer J, Balzer T, Blakeborough A, Carter R, et al. Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 2008;18:457-67. (Pubitemid 351248177)
3. Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004;230:266-75. (Pubitemid 37549812)
4. Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT - initial observations. Radiology 2005;234:468-78. (Pubitemid 40139918)
5. Vogl TJ, Kummel S, Hammerstingl R, Schellenbeck M, Schumacher G, Balzer T, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996;200:59-67. (Pubitemid 26197732)
6. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 2008;43:504-11.
7. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007;6:43-52.
8. Hamm B, Staks T, Muhler A, Bollow M, Taupitz M, Frenzel T, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995;195:785-92.
9. Reimer P, Rummeny EJ, Daldrup HE, Hesse T, Balzer T, Tombach B, et al. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 1997;7:275-80. (Pubitemid 127538595)
10. Kanematsu M, Hoshi H, Itoh K, Murakami T, Hori M, Kondo H, et al. Focal hepatic lesion detection: comparison of four fat-suppressed T2-weighted MR imaging pulse sequences. Radiology 1999;211:363-71. (Pubitemid 29206802)
11. Lee SS, Byun JH, Hong HS, Park SH, Won HJ, Shin YM, et al. Image quality and focal lesion detection on T2-weighted MR imaging of the liver: comparison of two high-resolution free-breathing imaging techniques with two breath-hold imaging techniques. J Magn Reson Imaging 2007;26:323-30.
12. Parikh T, Drew SJ, Lee VS, Wong S, Hecht EM, Babb JS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008;246:812-22.
13. Malone D, Zech CJ, Ayuso C, Bartolozzi C, Jonas E, Tanimoto A. Magnetic resonance imaging of the liver: consensus statement from the 1st International Primovist User Meeting. Eur Radiol 2008;18:D1-16.
14. 2-weighted MR images before and after the administration of gadoxetic acid. J Magn Reson Imaging 2009;30:437-43.
15. Chang SD, Thoeni RF. Effect of T1 shortening on T2-weighted MRI sequences: comparison of hepatic mass conspicuity on images acquired before and after gadolinium enhancement. AJR Am J Roentgenol 2008;190:1318-23. (Pubitemid 351684907)
16. Jeong YY, Mitchell DG, Holland GA. Liver lesion conspicuity: T2-weighted breath-hold fast spin-echo MR imaging before and after gadolinium enhancement - initial experience. Radiology 2001;219:455-60. (Pubitemid 32336361)
17. Hirokawa Y, Isoda H, Maetani YS, Arizono S, Shimada K, Okada T, et al. Hepatic lesions: improved image quality and detection with the periodically rotated overlapping parallel lines with enhanced reconstruction technique - evaluation of SPIO-enhanced T2-weighted MR images. Radiology 2009;251:388-97.
18. Lee SS, Byun JH, Park BJ, Park SH, Kim N, Park B, et al. Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses. J Magn Reson Imaging 2008;28:928-36.
19. Chakraborty D, Yoon HJ, Mello-Thoms C. Spatial localization accuracy of radiologists in free-response studies: inferring perceptual FROC curves from mark-rating data. Acad Radiol 2007;14:4-18. (Pubitemid 44909513)
20. Altman DG. Some common problems in medical research. In: Altman DG, ed. Practical statistics for medical research. London, UK: Chapman & Hall, 1991: 403-8.
21. Martin J, Puig J, Darnell A, Donoso L. Magnetic resonance of focal liver lesions in hepatic cirrhosis and chronic hepatitis. Semin Ultrasound CT MR 2002;23:62-78. (Pubitemid 34157631)
22. Kim YK, Kim CS, Moon WS, Cho BH, Lee SY, Lee JM. MRI findings of focal eosinophilic liver diseases. AJR Am J Roentgenol 2005;184:1541-8. (Pubitemid 43821833)
23. Lin SP, Brown JJ. MR contrast agents: physical and pharmacologic basics. J Magn Reson Imaging 2007;25:884-99.
24. Reimer P, Schneider G, Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 2004;14:559-78. (Pubitemid 38444568)
25. Le Bihan D, Poupon C, Amadon A, Lethimonnier F. Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging 2006;24:478-88. (Pubitemid 44320549)
26. Bruegel M, Holzapfel K, Gaa J, Woertler K, Waldt S, Kiefer B, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008;18:477-85. (Pubitemid 351248179)
27. Chen CY, Li CW, Kuo YT, Jaw TS, Wu DK, Jao JC, et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants - initial experience. Radiology 2006;239:448-56.